-
Most Recent
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Other industries you might be interested in
Recent Biotech Stocks Articles
CELG to Break Triple Digits
Celgene Corp. has flashed two buy signals in the past week. Get the target.
Amylin Gets a Boost From Its Diabetes Drug Approval
FDA approval of Bydureon -- a once-a-week injectable drug -- could make Amylin a takeover target for a Big Pharma.
Someone Has to Crunch All That Clinical Trial Data
That's where a slew of info-tech companies, ranging from giant Oracle to tiny BioClinica, come in. However, investing is them is no slam dunk.
Small Patient Population? Charge $400K a Year for Your Drug
Companies like BioMarin Pharmaceutical are cashing in on rare diseases, where they can charge hundreds of thousands of dollars every year for their drugs.
Roche’s Hostile Bid for Illumina Could Reach $60 Per Share
Swiss health care giant Roche made a hostile bid to buy Illumina for $44.50 per share, but many think that number will be higher when all is said and done.
Do Magic Mushrooms Hold the Key to Treating Depression?
Controversial British researcher touting use of "magic mushroom" compound psilocybin in treating depression as illegal drugs move further into pharma forefront.
5 Booming Biotech And Health Care Stocks to Buy Now
These biotech and health care companies are booming with positive returns. Take advantage of one of the biggest sector trends before it's too late.
If Novartis’ MS Drug Falters, Biogen Will Gain
After the deaths of 11 people who were taking the drug, concerns that Gilenya may cause heart problems has hit NVS hard, ending the stock's months-long upswing.
The Little Guys Are Pharma’s New Stars
Small and midsize drugmakers are where the action is -- in both research and M&A activity. For healthy dividends, however, Big Pharma still rules.
XLV Provides a Healthy Dose of Pfizer
If the health care sector is a must-have for your portfolio, and Pfizer is at the top of that list -- here's a way to get a healthier dose.
Are Pharma’s ‘Good Old Days’ Gone Forever?
You bet they are: Patent losses, a higher bar for FDA approvals, and slew of smaller, nimbler rivals have reshaped the industry.
Novartis Cutting 2,000 Jobs – So Much for Healthy Healthcare Stocks!
Novartis NYSE:NVS is cutting nearly 2,000 jobs in the United States. The reason? Patent expiration for its blockbuster blood pressure drug Diovan.
Merck Is Shopping for Smarts In Hep C
The pharma giant says it's determined to be the leader in treatments for the disease -- a market that is expected to hit $20 billion by 2020.
8 Pharma Stocks in Good Health
The health care sector is a field that will continue to grow as Baby Boomers get old and retire. These eight companies will be at the center of this trend.
WebMD’s Business Model May Need Surgery
Big Pharma’s ad pullback and competition from social media have slammed the health-info site. In fact, the biggest threat to WebMD may be Facebook and Twitter.
Idenix and Achillion Jump on Takeover Talk
Their hepatitis C drugs could be lures for Big Pharma after a rival gets a juicy offer from Bristol-Myers Squibb.
Where to Invest During the Last Stage of the Market Recovery
Add these stocks from the consumer staples, health care and utilities sectors during this final stage in the U.S. economy's recovery.
Top 5 Emerging Growth Stocks to Buy for January
The list of the top five emerging growth stocks to buy for January include tech and pharmaceutical companies -- as well as a "monster" beverage play.
